News & Updates

Positive urine culture tied to postsurgery infections

29 Aug 2024

Postoperative infections tend to occur more often in patients with a positive urine culture, including preoperative polymicrobial urine culture, prior to urological surgery, reports a study. In addition, those with infectious complications are prone to experiencing other complications.

Positive urine culture tied to postsurgery infections

29 Aug 2024

Hypo-, hypercalcaemia prevalent among predialysis CKD patients with MBD

29 Aug 2024 by

Episodes of hypocalcaemia and hypercalcaemia are relatively high among predialysis patients with chronic kidney disease (CKD), but the prevalence of these conditions does not seem to contribute to a higher risk of mortality and cardiovascular events, according to a Singapore study.

Hypo-, hypercalcaemia prevalent among predialysis CKD patients with MBD

29 Aug 2024

Circulating IL-17A predicts CVD in early RA

29 Aug 2024

Circulating interleukin (IL)-17A in patients diagnosed with rheumatoid arthritis (RA) is associated with the incidence of cardiovascular disease (CVD), independent of traditional CVD risk factors and of erythrocyte sedimentation rate (ESR) at the time of diagnosis, suggests a study.

Circulating IL-17A predicts CVD in early RA

29 Aug 2024

Novel GLP-1/GCG receptor agonist shows promise against noncirrhotic MASH with fibrosis

29 Aug 2024

Dual glucagon-like peptide-1 (GLP-1) and glucagon (GCG) receptor agonism with cotadutide has shown a signal of benefit in the treatment of noncirrhotic metabolic dysfunction-associated steatohepatitis (MASH) with fibrosis, according to the phase II PROXYMO trial.

Novel GLP-1/GCG receptor agonist shows promise against noncirrhotic MASH with fibrosis

29 Aug 2024

Add-on niraparib maintenance confers PFS benefit in endometrial cancer

29 Aug 2024 by

The addition of a PARP inhibitor (PARPi), niraparib, to dostarlimab plus chemotherapy significantly improved progression-free survival (PFS) among patients with primary advanced or recurrent endometrial cancer, including those with mismatch repair proficient (MMRp)/microsatellite stable (MSS) tumours, according to results from part 2 of the RUBY trial presented at ESMO Gyn 2024.

Add-on niraparib maintenance confers PFS benefit in endometrial cancer

29 Aug 2024

Dad’s preconception HBV infection tied to baby’s heart defects

28 Aug 2024 by

A preconception history of hepatitis B virus (HBV) infection among fathers carries an increased risk of congenital heart disease (CHD) in offspring, as shown in a study.

Dad’s preconception HBV infection tied to baby’s heart defects

28 Aug 2024

AI-based ECG predicts biventricular dysfunction, dilation in CHD

28 Aug 2024

An ECG enhanced by artificial intelligence (AI) demonstrates its capability in detecting biventricular dysfunction and dilation in patients with congenital heart disease (CHD).

AI-based ECG predicts biventricular dysfunction, dilation in CHD

28 Aug 2024

Rivaroxaban eases ischaemic events, ups bleeding in frail patients after revascularization

28 Aug 2024 by

The risks of ischaemic complications and bleeding are higher among patients with peripheral artery disease (PAD) who meet the frailty criteria after lower extremity revascularization in the VOYAGER PAD study. Regardless of frailty status, use of rivaroxaban lowers the ischaemic risk and increases bleeding.